|
|
||||||||
Clinical Chemistry, Vol 33, 2074-2078, Copyright © 1987 by American Association for Clinical Chemistry
J Widdershoven, P van Munster, R De Abreu, H Bosman, T van Lith, M van der Putten-van Meyel, K Motohara and I Matsuda
Laboratory of the Department of Pediatrics and Surgery, Nijmegen University Hospital, The Netherlands.
PIVKA-II (Protein Induced by Vitamin K Absence) is abnormal des- carboxylated prothrombin, which is present in vitamin K deficiency or in patients using warfarin. With a sensitive method for PIVKA-II, biochemical vitamin K deficiency can be established before clinical symptoms occur. We give an overview of methods used to detect PIVKA-II, and four selected methods are inter-compared: (a) measuring total factor II including PIVKA-II by using Echis carinatus snake venom as an activator of prothrombin; (b) measuring PIVKA-II by using snake venom as an activator of factor II after adsorption of functional factor II onto barium sulfate; (c) electrophoresis-immunofixation method; and (d) enzyme immunoassay. We found d to be the most sensitive and reliable method for PIVKA-II.
The following articles in journals at HighWire Press have cited this article:
![]() |
S. L Booth, I. Golly, J. M Sacheck, R. Roubenoff, G. E Dallal, K. Hamada, and J. B Blumberg Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status Am. J. Clinical Nutrition, July 1, 2004; 80(1): 143 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rashid, P. Durie, M. Andrew, D. Kalnins, J. Shin, M. Corey, E. Tullis, and P. B Pencharz Prevalence of vitamin K deficiency in cystic fibrosis Am. J. Clinical Nutrition, September 1, 1999; 70(3): 378 - 382. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |